Skip to content

NEPHROQUIN

Active Private limited companyfounded 2019active for 7 yearsRue des Ecomines 32, 4900 SpaKBO/BCE: BE 0721.598.242 #8 company by equity in Spa, Health and social work sector

Lifetime

7 annual accounts with figures on one time axis
peak of €167,738 in 2025
€167,738▲ 34.1%
peak of €118,486 in 2019
€108,172▲ 35.8%
peak of €327,980 in 2025
€327,980▲ 17.2%
€127,598▼ 10.2%
Board2 names since 2019
1 director
Documentsfilings and deeds
01-07-202630 days before the deadline
2025micro format
Gross margin from €125,059 to €167,738Result from €79,664 to €108,172Dividend €60,000Equity from €279,808 to €327,980

Key points

from the 2025 annual accounts

Equity

€327,980 ▲ 17.2%
279,8082024+108,172Profit-60,000Dividend327,9802025

NEPHROQUIN paid out €60,000 in dividends. That is 55% of the 2025 profit.

Turnover

≈ €300,000 estimated

The micro format states no turnover.

Filings

7 annual accounts 1 late
AprilJune31 JulyOctober202020222024

The 2022 accounts came 31 days late. The other six were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,785 companies had the same profile as NEPHROQUIN has now. Each dot stands for 17 companies, two years later.

96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,785 companies, not a prediction for NEPHROQUIN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 22-09-2021
  • 100 sharesdeed of 24-11-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0721598242
Capital increase of €1,000 100 new shares · Contribution by · General meeting of 13-10-2021 · Gazette deed
changes role from manager to director appointed as director · Discharge granted to · General meeting of 22-09-2021 · Gazette deed
New establishment in Spa Avenue Reine Astrid 54
All 17 events

Comparable companies

same main activity, similar in size and age
Company
NEPHROQUIN Spa €455,578 €167,738 72.0% -
Docteur SAMI DEMIR Ans €421,131 €188,807 52.0% -
Artsenpraktijk Goede Weide Scherpenheuvel-Zichem €449,226 €159,465 53.7% -
Dokter Wim Van Damme, huisarts Lokeren €503,402 €174,080 97.6% -
Dr. Roelandts Lieven - Huisarts Rumst €515,904 €172,256 67.4% -
Dr. Richard Demmers Ranst €498,854 €173,734 35.7% -
ATRIUMEDICAL Molenbeek-Saint-Jean €465,704 €154,127 6.1% -

These companies have the same main activity as NEPHROQUIN: general medical practice (NACE 86210). They are comparable in size and age: total assets between €421,000 and €516,000, founded between 2018 and 2019.

Official details

Source: KBO
Status
Active since 26-02-2019Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment units
2.286.860.0234900 Spa, since 27-03-2019
2.325.206.5964900 Spa, since 01-10-2021
Financial year end
31 December
Peppol
Reachable since 21-03-2025
Company details

Annual accounts 2025

€455,578▲ 8.0%
Filing
Filed on 01-07-2026, 30 days before the end of the filing period
Financials

Insights on NEPHROQUIN

NEPHROQUIN files the micro format. That format states no turnover. The gross margin rose from €161,143 in 2019 to €167,738 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEPHROQUIN

What is the company number of NEPHROQUIN?
The company number of NEPHROQUIN is 0721.598.242. The VAT number is the same number with BE in front: BE 0721.598.242.
Where is NEPHROQUIN based?
The registered office is at Rue des Ecomines 32, 4900 Spa.Company details
What does NEPHROQUIN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of NEPHROQUIN?
NEPHROQUIN is a private limited company (BV).
When was NEPHROQUIN founded?
NEPHROQUIN was founded on 26-02-2019.
Is NEPHROQUIN still active?
Yes, NEPHROQUIN is an active enterprise in the KBO register.
What is the turnover of NEPHROQUIN?
The turnover in financial year 2025 is about €300,000. This figure is estimated from the gross margin of €167,738 and 30 comparable companies (NACE 86210). It probably lies between €240,000 and €380,000. In financial year 2022 turnover was €194,427.Financials
Is NEPHROQUIN profitable?
In financial year 2025, NEPHROQUIN made a profit of €108,172.
Where can I find the annual accounts of NEPHROQUIN?
NEPHROQUIN filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEPHROQUIN due?
NEPHROQUIN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.